CLARITY MEDICAL (01406) Reorganizes Special Committee and Independent Special Committee

Stock News
2025/11/11

CLARITY MEDICAL (01406) announced that the Board of Directors passed the following resolutions at a meeting held on November 11, 2025: (1) Immediate termination of PricewaterhouseCoopers Consulting Hong Kong Limited as the forensic advisor to the Special Committee; (2) Immediate restructuring of the Special Committee, with Ci Ying (appointed as an Independent Non-Executive Director on June 25, 2025) and Dr. Chen Pou-kin (newly appointed Independent Non-Executive Director at the Board meeting) replacing Ms. Zheng and Mr. Wang as members; and (3) Immediate restructuring of the Independent Special Committee, where Zheng Yuling and Wang Can will no longer serve as members, while Dr. Chen Pou-kin will join as a new member. Following this reorganization, the committee will consist of Li Jinhong (Chairman), Ms. Ci, and Dr. Chen Pou-kin.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10